News 15 mai 2024 Allegria Therapeutics raises 3.5 million dollars in seed financing round Allegria Therapeutics has received seed funding of 3.5 million dollars from the founding investor Forty51 Ventures. The biotech startup is develo...
Aktuell 15 mai 2024 Allegria Therapeutics nimmt 3,5 Millionen Dollar in Seed-Runde ein Allegria Therapeutics hat eine Seed-Finanzierung von 3,5 Millionen Dollar durch den Gründungsinvestor Forty51 Ventures erhalten. Das Biotech-Star...
Registrazioni video 14 mai 2024 Webinar sul regolamento UE sull’IA: attuazione entro il 2026 - come prepararsi? Operate nell'UE e i vostri prodotti e servizi utilizzano l'IA o gli algoritmi? Quali precauzioni dovete prendere e quali certificazioni dovete...
Aktuell 24 mai 2024 Geistlich erhält EU-Zertifizierung für Kollagen-Portfolio Geistlich Pharma hat die MDR-Zertifizierung für seine Kollagen-Produktpalette erhalten und erfüllt damit die neuen EU-Vorschriften. Die Produkte ...
News 24 mai 2024 Geistlich receives EU certification for collagen portfolio Geistlich Pharma has received MDR certification for its collagen product range and thus meets the new EU requirements. The products will be used ...
News 22 mai 2024 CUTISS secures 25 million Swiss francs from investors CUTISS has closed a first Series C financing round in the amount of 25 million Swiss francs. With this, the life sciences company with a focus on...
News 03 mai 2024 Basel research paves way for new drugs Chemists at the University of Basel have developed a new synthesis approach to artificially create terpenes. These contain substances that can be...
Success stories 23 abr 2024 How BeiGene drives global cancer treatment access From its European headquarters in Basel, Switzerland, BeiGene strategically collaborates with stakeholders worldwide to advance oncology research...
Exemples de Réussite 02 mai 2024 Comment BeiGene favorise l’accès au traitement du cancer à l’échelle mondiale Depuis son siège européen à Bâle, en Suisse, BeiGene collabore de manière stratégique avec des parties prenantes dans le monde entier pour f...
News 25 abr 2024 Swiss biotech achieves record revenues in 2023 Swiss biotech companies generated record revenues of 7.3 billion Swiss francs in 2023, while capital investments rose 50 per cent year on year to...
News 23 abr 2024 Swibrace advances to clinical phase with innovative 3D-printed wrist braces Swibrace, in partnership with the Inselspital in Bern, moves its customized wrist braces into clinical phase, enhancing fracture treatment throug...
News 10 abr 2024 Empa researchers develop cellulose-based aerogel A laboratory at the Swiss Federal Laboratories for Materials Science and Technology (Empa) has developed an ultralight, biodegradable and printab...
Actualités 23 abr 2024 Les orthèses de poignet innovantes imprimées en 3D de Swibrace passent à la phase clinique Swibrace, en partenariat avec l’Inselspital de Berne, fait passer ses attelles de poignet personnalisées en phase clinique, améliorant ainsi le t...
News 04 dez 2023 Cradle raises 24 million US dollars Cradle has raised 24 million dollars in a Series A funding round. The biotech startup has developed a platform that enables biologists to design ...
News 26 mar 2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
News 18 mar 2024 Neuria enters Vanguard Accelerator to gameify healthier lifestyles Neuria Digital Therapeutics has become the inaugural start-up of 2024 to be embraced by the Vanguard Accelerator program.
Aktuell 04 dez 2023 Cradle stockt Kapital um 24 Millionen Dollar auf Cradle hat eine Serie A-Finanzierung von 24 Millionen Dollar eingenommen. Das Biotech-Start-up hat eine Plattform entwickelt, auf der Biologen un...
News 31 out 2023 Viso.ai raises 9.2 million US dollars in fresh capital Viso.ai has raised 9.2 million US dollars in a financing round. With this fresh capital, the company will strive to satisfy increased demand for ...